Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33731101416;101417;101418 chr2:178535424;178535423;178535422chr2:179400151;179400150;179400149
N2AB3209096493;96494;96495 chr2:178535424;178535423;178535422chr2:179400151;179400150;179400149
N2A3116393712;93713;93714 chr2:178535424;178535423;178535422chr2:179400151;179400150;179400149
N2B2466674221;74222;74223 chr2:178535424;178535423;178535422chr2:179400151;179400150;179400149
Novex-12479174596;74597;74598 chr2:178535424;178535423;178535422chr2:179400151;179400150;179400149
Novex-22485874797;74798;74799 chr2:178535424;178535423;178535422chr2:179400151;179400150;179400149
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Fn3-132
  • Domain position: 43
  • Structural Position: 50
  • Q(SASA): 0.2515
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A rs746383312 -0.888 0.963 N 0.501 0.29 0.162503812791 gnomAD-2.1.1 4.02E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.87E-06 0
T/A rs746383312 -0.888 0.963 N 0.501 0.29 0.162503812791 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1218 likely_benign 0.1023 benign -0.652 Destabilizing 0.963 D 0.501 neutral N 0.430091813 None None N
T/C 0.7565 likely_pathogenic 0.6875 pathogenic -0.317 Destabilizing 1.0 D 0.623 neutral None None None None N
T/D 0.7169 likely_pathogenic 0.608 pathogenic -0.029 Destabilizing 0.999 D 0.584 neutral None None None None N
T/E 0.5941 likely_pathogenic 0.4877 ambiguous -0.088 Destabilizing 1.0 D 0.583 neutral None None None None N
T/F 0.7144 likely_pathogenic 0.6046 pathogenic -0.986 Destabilizing 1.0 D 0.696 prob.neutral None None None None N
T/G 0.4161 ambiguous 0.3509 ambiguous -0.829 Destabilizing 1.0 D 0.629 neutral None None None None N
T/H 0.6807 likely_pathogenic 0.5709 pathogenic -1.142 Destabilizing 1.0 D 0.677 prob.neutral None None None None N
T/I 0.3933 ambiguous 0.2938 benign -0.291 Destabilizing 1.0 D 0.634 neutral N 0.474498738 None None N
T/K 0.4855 ambiguous 0.3941 ambiguous -0.593 Destabilizing 1.0 D 0.586 neutral None None None None N
T/L 0.219 likely_benign 0.1691 benign -0.291 Destabilizing 0.999 D 0.553 neutral None None None None N
T/M 0.2014 likely_benign 0.1581 benign 0.05 Stabilizing 1.0 D 0.625 neutral None None None None N
T/N 0.3074 likely_benign 0.2308 benign -0.356 Destabilizing 0.999 D 0.661 neutral N 0.453027388 None None N
T/P 0.2242 likely_benign 0.1769 benign -0.381 Destabilizing 0.202 N 0.35 neutral N 0.454470183 None None N
T/Q 0.4818 ambiguous 0.3926 ambiguous -0.615 Destabilizing 1.0 D 0.648 neutral None None None None N
T/R 0.4925 ambiguous 0.3858 ambiguous -0.279 Destabilizing 1.0 D 0.633 neutral None None None None N
T/S 0.2135 likely_benign 0.1745 benign -0.608 Destabilizing 0.982 D 0.521 neutral N 0.435113631 None None N
T/V 0.2292 likely_benign 0.192 benign -0.381 Destabilizing 0.999 D 0.562 neutral None None None None N
T/W 0.9377 likely_pathogenic 0.9011 pathogenic -0.923 Destabilizing 1.0 D 0.689 prob.neutral None None None None N
T/Y 0.7785 likely_pathogenic 0.6663 pathogenic -0.688 Destabilizing 1.0 D 0.692 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.